Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer.
Frederiksen, C
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Feb 2011 - 369-75 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1569-8041
10.1093/annonc/mdq354 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Capecitabine
Colorectal Neoplasms--drug therapy
Deoxycytidine--analogs & derivatives
Female
Fluorouracil--analogs & derivatives
Humans
Male
Middle Aged
Neoplasm Metastasis
Oxaloacetates
Survival Analysis
Tissue Inhibitor of Metalloproteinase-1--blood
Treatment Outcome
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Feb 2011 - 369-75 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1569-8041
10.1093/annonc/mdq354 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Capecitabine
Colorectal Neoplasms--drug therapy
Deoxycytidine--analogs & derivatives
Female
Fluorouracil--analogs & derivatives
Humans
Male
Middle Aged
Neoplasm Metastasis
Oxaloacetates
Survival Analysis
Tissue Inhibitor of Metalloproteinase-1--blood
Treatment Outcome